(1,3-DIHYDROFURO[3,4-C]PYRIDIN-6-YL)METHANOL, 95.0%, 1g

2,4-Dimethoxyquinoline, 95.0%, 100mg

3-(2-(2-aminoethoxy)ethyl)oxazolidine-2,4-dione hydrochloride, 95.0%, 250mg

1-(Piperidin-1-yl)octadecan-1-one, 98%, 5g

7-Chloro-6-methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, 98%, 1g

Nalpha-(5-Fluoro-2,4-dinitrophenyl)-D-leucinamide [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)1g

2-(3,5-Dichloro-4-methoxyphenyl)4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

3-Methyl-6-(1-methylhydrazinyl)pyridazine, 95.0%, 1g

5,7-Difluorochroman-4-ol, 95%, 1g

5,6-Dimethylquinolin-8-amine, 98%, 1g

Lithium nonafluorobutanesulfonate, 95.0%, 25g

(Z)-2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)acrylic acid, 98%, 250mg

Methyl 2,4-dibromobenzoate, 95.0%, 1g